Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1522282 (
EMT
)
2,868
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pathogenesis of cervical cancer (CC) at molecular level has attracted much research attention. The current study aimed to explore the effects of LncRNA
TDRG1
on cellular process in CC cells and its molecular mechanism. Expressions of
TDRG1
and miR-214-5p in CC and normal tissues and CC cells were measured by quantitative real-time polymerase chain reaction (qRT-PCR). The effects of
TDRG1
, miR-214-5p, and SOX4 on cell proliferation, migration, invasion, and
EMT
process of CC cells were detected by Cell Counting Kit-8 (CCK-8), colony formation, wound-healing, Transwell, and Western blot assays, respectively. StarBase and Targetscan7.2 were used to predict the target genes of
TDRG1
and miR-214-5p, and the predictions were verified by dual-luciferase reporter assay. The expression of SOX4 in CC and normal tissues, and CC cells transfected with siTDRG1 or miR-214-5p inhibitor was determined by qRT-PCR. The results showed that expression of
TDRG1
was up-regulated, while that of miR-214-5p was down-regulated in CC. The target genes of
TDRG1
and miR-214-5p were verified to be miR-214-5p and SOX4, respectively. Knocking down
TDRG1
expression could inhibit cell proliferation, colony, migration, and invasion abilities, and
EMT
process, whereas the inhibition of miR-214-5p expression partially reversed such results. Moreover, high SOX4 expression was observed in CC tissues, and down-regulating
TDRG1
expression reduced the SOX4 expression while down-regulating miR-214-5p expression alleviated such an inhibition. In conclusion,
TDRG1
acts as cancer promoter in CC through promoting cell proliferation, migration, invasion, and
EMT
process to modulate SOX4 expression through adsorbing miR-214-5p.
...
PMID:LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4. 3210 39